Literature DB >> 12505046

How surgeon age affects surveillance strategies for extremity soft tissue sarcoma patients after potentially curative treatment.

Keita Sakata1, Alan L Beitler, John F Gibbs, William G Kraybill, Katherine S Virgo, Frank E Johnson.   

Abstract

BACKGROUND: The optimal strategy for follow-up of extremity soft tissue sarcoma patients after potentially curative treatment remains unknown. We investigated whether the date of completion of formal surgical training affects choice of surveillance strategy.
MATERIALS AND METHODS: The 1,592 members of the Society of Surgical Oncology were asked how often they use 12 separate surveillance modalities during years 1-5 and 10 postsurgery. The motivation underlying follow-up was assessed separately. Repeated-measures analysis of variance was used to compare practice patterns by the year in which the surgeon's formal surgery training was completed, controlling for tumor grade, tumor size, and year postsurgery.
RESULTS: Of the 716 respondents, 318 performed surgery and also provided long-term postoperative surveillance for their patients. These respondents were considered evaluable. Erythrocyte sedimentation rate, extremity X ray, and bone scan were the follow-up tests which differed significantly among physician age groups. Surgeons who completed training more than 30 years ago ordered erythrocyte sedimentation rate more frequently (P < 0.001). Surgeons in the 21-30 year category ordered extremity X ray and bone scan more frequently (P < 0.05), but the absolute differences among age groups were quite small. Older surgeons were also significantly more likely to believe that follow-up is clinically worthwhile.
CONCLUSIONS: The posttreatment surveillance practice patterns of the members of the Society of Surgical Oncology caring for extremity soft tissue sarcoma patients vary only marginally with the length of time since completion of training. Postgraduate education may be one factor homogenizing surgeon behavior in this important aspect of cancer patient care.

Entities:  

Mesh:

Year:  2002        PMID: 12505046     DOI: 10.1006/jsre.2002.6544

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  5 in total

Review 1.  [Surveillance in patients with bone sarcomas. When, how, and for how long?].

Authors:  H R Dürr; P-U Tunn; Y Bakhshai
Journal:  Unfallchirurg       Date:  2014-06       Impact factor: 1.000

2.  Evaluating the Impact of Surveillance Follow-Up Intervals in Patients Following Resection of Primary Well-Differentiated Liposarcoma of the Retroperitoneum.

Authors:  Emily Z Keung; Nikita Rajkot; Keila E Torres; Neeta Somaiah; Kelly K Hunt; Barry W Feig; Christopher P Scally; Naruhiko Ikoma; Christina L Roland
Journal:  Ann Surg Oncol       Date:  2020-05-14       Impact factor: 5.344

3.  Follow up after Primary Treatment of Soft Tissue Sarcoma: A Survey of Current Practice in the United Kingdom.

Authors:  C H Gerrand; L J Billingham; P J Woll; R J Grimer
Journal:  Sarcoma       Date:  2007

Review 4.  Follow-up in soft tissue sarcomas.

Authors:  Piotr Rutkowski; Iwona Lugowska
Journal:  Memo       Date:  2014-06-13

5.  Management of Soft Tissue Sarcomas in Extremities: Variation in Treatment Recommendations and Surveillance According to Specialty and Continent.

Authors:  Ibtissam Acem; Merel M Smit; Cornelis Verhoef; Winan J van Houdt; Rick L Haas; Jos A van der Hage; Dirk J Grünhagen; Michiel A J van de Sande
Journal:  Ann Surg Oncol       Date:  2021-05-10       Impact factor: 5.344

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.